Research study Program year 2021 Source: CMS Open Payments

Gtp1 Phase I Longitudinal Study

Research payments

$2,108,637

53 payments

Through program year 2021, $2,108,637 in research payments was reported against Gtp1 Phase I Longitudinal Study, across 53 payments, paid by Genentech, Inc..

Paid by: Genentech, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$65,285	1
2020	Research	$1,437,519	16
2019	Research	$605,832	36

Breakdown

Who paid Research payments · program years 2019–2021

Genentech, Inc. $2,108,637 53 payments

Who received the money Research payments · program years 2019–2021

Molecular Neuroimaging LLC Organisation paid for research $1,751,771 15 payments
Neurostudies Network LLC Organisation paid for research $117,280 10 payments
Institute For Neurodegenerative Disorders Organisation paid for research $57,365 1 payment
Compass Research North Organisation paid for research $47,864 9 payments
Dranil Nair MD Private Office Organisation paid for research $41,901 3 payments
Emory University Hospital Teaching hospital · GA $28,927 5 payments
Bio Behaviorhal Health Organisation paid for research $17,736 1 payment
Miami Jewish Health Systems Inc Organisation paid for research $12,193 2 payments
Rhode Island Mood And Memory Research Institute Organisation paid for research $9,692 1 payment
Erg Holding Company LLC Organisation paid for research $8,914 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.